Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Cash & Equivalents (2016 - 2025)

Alkermes (ALKS) has disclosed Cash & Equivalents for 16 consecutive years, with $388.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 33.46% to $388.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $388.6 million, a 33.46% increase, with the full-year FY2025 number at $388.6 million, up 33.46% from a year prior.
  • Cash & Equivalents was $388.6 million for Q4 2025 at Alkermes, down from $616.4 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $665.8 million in Q2 2023 to a low of $205.0 million in Q1 2021.
  • A 5-year average of $393.3 million and a median of $363.1 million in 2021 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: surged 161.46% in 2023, then crashed 38.82% in 2024.
  • Alkermes' Cash & Equivalents stood at $337.5 million in 2021, then decreased by 13.35% to $292.5 million in 2022, then surged by 56.41% to $457.5 million in 2023, then plummeted by 36.36% to $291.1 million in 2024, then skyrocketed by 33.46% to $388.6 million in 2025.
  • Per Business Quant, the three most recent readings for ALKS's Cash & Equivalents are $388.6 million (Q4 2025), $616.4 million (Q3 2025), and $521.2 million (Q2 2025).